M. Peake (Leicester, United Kingdom), M. Pesek (Plzen, Czech Republic)
Treatment of malignant pleural mesothelioma with caelyx: few responses but good survival
G. Hillerdal, J. B. Sorensen, A. Vikstrom (Stockholm, Linkoping, Sweden; Copenhagen, Denmark)
|  |
Treatment of malignant pleural mesothelioma with combination of carboplatin, caelyx, and gemzitabine: the CCG study of the Nordic mesothelioma group
G. Hillerdal, J. B. Sorensen, S. Sundstrom, H. Riska, A. Vikstrom (Stockholm, Linkoping, Sweden; Copenhagen, Denmark; Trondheim, Norway; Helsinki, Finland)
| |
Local (LICT) and systemic immunochemotherapy (SICT) after surgery in malignant pleural mesothelioma (MPM)
A. Chella, C. Tibaldi, I. Bernardini, M. Lucchi, G. Toma, M. G. Vichi, A. Mussi, A. Falcone, N. Ambrosino (Pisa, Livorno, Italy)
| |
Multimodality therapy for malignant pleural mesothelioma
A. Orki, M. Keles, C. Aydemir, S. Urek, H. Kiral, A. Kosar, C. Dudu, B. Arman (Istanbul, Turkey)
| |
Chemotherapy for treatment of malignant pleural mesothelioma
M. Metintas, G. Ak, F. Alatas, I. Ucgun, H. Yildirim, E. Harmanci, S. Erginel, S. Metintas (Eskisehir, Turkey)
| |
Malignant and non-malignant asbestos-related pleural and lung disease: 10-year follow-up study
S. Cvitanovic, Z. Ivancevic (Split, Croatia)
| |
Pleural mesothelioma. Preliminary data of a consecutive series from 16 hospital in Madrid
V. Villena, Y. W. Pun (Madrid, Spain)
| |
A case report: surprising diagnosis of malignant mesothelioma in a patient with malignant pleural effusion, mediastinal lymphoma and intestinal carcinoma in situ
S. Sohrab, S. Albrecht, G. Rott, A. Thiel, C. Maurer (Duisburg, Germany)
| |
Diagnosis of malignant pleural mesothelioma
A. Debeljak, P. Kecelj, I. Kern, S. Vidmar, V. Kovaè (Golnik, Ljubljana, Slovenia)
| |
Malignant mesothelioma: recent experience
C. Lopes, R. Sotto-Mayor, E. Teixeira, M. Canotilho, B. Almeida (Lisbon, Portugal)
| |
Medical thoracoscopy for diagnosis of pleural effusion in cancer patients
K. Nagata, Y. Iwasaki, T. Yuba, K. Khono, S. Hosogi, S. Ohsugi, H. Kuwahara, Y. Takemura, I. Yokomura (Kyoto, Japan)
| |
Retrospective assessment of diagnostic yield of percutaneous transthoracic pleural biopsy in malignant pleural effusions
R. Mukherjee, H. Moudgil, K. S. Srinivasan (Telford, United Kingdom)
| |
Clinical significance of CEA, NSE, CYFRA 21-1 in serum and pleural fluid for the diagnosis of malignant pleural effusion associated with primary lung cancer
J. H. Chang, J. H. Lee (Seoul, South Korea)
| |
The diagnostic usefulness of MAGE expression in the diagnosis of exudative pleural effusion
Y. J. Jeon, K. C. Kim, W. I. Choi, S. B. Han, J. W. Park, C. H. Jeon (Daegu, South Korea)
| |
Diagnostic value of linear combination of CYFRA 21-1 and carcinoembryonic antigen in malignant pleural effusions
D. Kavkova, E. Varmusova, I. Tudik, J. Mocak, B. Balla (Poprad - Kvetnica, Bratislava, Slovakia)
| |
Evaluation of dendritic cells in peripheral blood and pleural effusion of non-small-cell lung cancer patients
A. Surdacka, S. Chocholska, I. Jastrzebska, J. Milanowski, J. Rolinski (Lublin, Poland)
| |
Pathomorphology of pretumor condition and lung cancer in persons engaged in radionuclide industry
A. E. Ali-Risa, T. G. Barkhina, M. V. Samsonova, A. L. Cherniaev (Moscow, Russia)
| |
Bronchy-pulmonary carcinoma in post-war period
K. K. Jandric, M. J. Stanetic, T. Barac, N. Petkovic (Banja Luka, Bosnia)
| |
Ultrastructural research of changes in bronchus, lungs and ovaries in different types of neoplasmic lesions
T. G. Barkhina, L. M. Mikhaleva, A. E. Ali-Risa, E. A. Moroz, N. N. Vorobiyova (Moscow, Russia)
| |
Bilateral lungs dissemination on radionuclides polluted territories
Y. Voloshyn, B. Radionov, E. Suslov, M. Jatsyna (Kiev, Ukraine)
| |